NCT01227811View on ClinicalTrials.gov

Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2011

Conditions
Bioequivalency
Interventions
DRUG

Darifenacin

Single oral dose Darisec(R) 15.0 mg

DRUG

Darifenacin

Single oral dose Enablex(R) 15 mg

Trial Locations (1)

11600

Center for Clinical Pharmacology Research Bdbeq S.A.; Hospital Italiano de Montevideo.., Montevideo

Sponsors
All Listed Sponsors
collaborator

Laboratorio Elea Phoenix S.A.

INDUSTRY

lead

Center for Clinical Pharmacology Research Bdbeq S.A.

OTHER